Pediatric Ethanol Lock Therapy Study.

Summary

This study is a double-blind crossover design to compare prophylaxis with ethanol lock therapy versus placebo lock therapy (heparin). The primary outcome measure will be the number of catheter related blood stream infections (CRBSI) in each time period.

Timeline

Start

2008-08

Primary completion

2014-12

Completion

2014-12

Outcome

Met primary endpoint

registry analysis (superiority or other test); Infections While Using Ethanol Lock vs Infections While Using Heparin Lock; p = 0.012; t-test, 2 sided NCT00948441 ↗

Drugs

Indications